GE HealthCare Techs Analyst Price Targets

Wall Street analyst price targets and consensus rating for GE HealthCare Techs (GEHC).

Price Target Range — 13 Quarters

Analyst Consensus — 19 Analysts

12Buy

7Hold

Consensus RatingBuy# Analysts19Avg. Consensus PT$84Upside to Avg. PT+4.1%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Nov 3, 2026	UBS	Graham Doyle	PT Raise	Neutral	$73→$80
Oct 29, 2026	JP Morgan	Robbie Marcus	PT Raise	Neutral	$70→$80
Oct 29, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$71→$79
Oct 29, 2026	RBC Capital	Kendall Au	PT Raise	Outperform	$80→$90
Oct 29, 2026	Barclays	Christopher Pasquale	PT Raise	Overweight	$85→$95
Oct 28, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$75→$83
Oct 12, 2026	BTIG	Ryan Zimmerman	PT Cut	Buy	$79→$75
Oct 7, 2026	Barclays	Christopher Pasquale	Initiate	Overweight	$85
Oct 5, 2026	Citigroup	Joanne Wuensch	PT Cut	Neutral	$75→$71
Oct 5, 2026	Needham	David Saxon	Maintained	Buy	$93
Sep 22, 2026	Needham	David Saxon	Initiate	Buy	$93
Sep 17, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$79
Aug 19, 2026	BTIG	Ryan Zimmerman	Maintained	Buy	$79
Jul 31, 2026	UBS	Graham Doyle	PT Raise	Neutral	$67→$73
Jul 30, 2026	Citigroup	Joanne Wuensch	PT Raise	Neutral	$69→$75
Jul 30, 2026	Evercore ISI Group	Vijay Kumar	PT Raise	Outperform	$80→$84
Jul 30, 2026	Wells Fargo	Larry Biegelsen	PT Raise	Overweight	$75→$85
Jul 29, 2026	BTIG	Ryan Zimmerman	PT Raise	Buy	$75→$79
Jul 17, 2026	Hovde Group	—	Initiate	Market Perform	$14
Jul 16, 2026	UBS	Graham Doyle	PT Cut	Neutral	$69→$67

Analyst Ratings News

PRO
UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

UBS analyst Graham Doyle maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $73 to $80.

Benzinga Newsdesk

PRO
JP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

JP Morgan analyst Robbie Marcus maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $70 to $80.

Benzinga Newsdesk

PRO
Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

Citigroup analyst Joanne Wuensch maintains GE HealthCare Techs (NASDAQ:GEHC) with a Neutral and raises the price target from $71 to $79.

Benzinga Newsdesk

PRO
RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

RBC Capital analyst Kendall Au maintains GE HealthCare Techs (NASDAQ:GEHC) with a Outperform and raises the price target from $80 to $90.

Benzinga Newsdesk

PRO
Barclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

Barclays analyst Christopher Pasquale maintains GE HealthCare Techs (NASDAQ:GEHC) with a Overweight and raises the price target from $85 to $95.

Benzinga Newsdesk

PRO
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

BTIG analyst Ryan Zimmerman maintains GE HealthCare Techs (NASDAQ:GEHC) with a Buy and raises the price target from $75 to $83.

Benzinga Newsdesk

GE HealthCare Technologies Inc

GE HealthCare Techs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PRO
UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PRO
JP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PRO
Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

PRO
RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

PRO
Barclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

PRO
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

People Also Watch

People Also Watch

GE HealthCare Technologies Inc

GE HealthCare Techs Analyst Price Targets

Recent Analyst Actions

Analyst Ratings News

PROUBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PROJP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PROCitigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

PRORBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

PROBarclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

PROBTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83

People Also Watch

People Also Watch

PRO
UBS Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PRO
JP Morgan Maintains Neutral on GE HealthCare Techs, Raises Price Target to $80

PRO
Citigroup Maintains Neutral on GE HealthCare Techs, Raises Price Target to $79

PRO
RBC Capital Maintains Outperform on GE HealthCare Techs, Raises Price Target to $90

PRO
Barclays Maintains Overweight on GE HealthCare Techs, Raises Price Target to $95

PRO
BTIG Maintains Buy on GE HealthCare Techs, Raises Price Target to $83